Comment on “Disulfiram as an anti-inflammatory agent: mechanisms, nano-delivery strategies, and applications in non-oncologic diseases” by Q. Jiang, M. Jiang, Y. Lv, X. Zhang, S. Wang and J. Zhao, RSC Adv. , 2025, 15 , 36344
RSC Advances · 2026 · 16 (34) · 33511-33512
DOI: 10.1039/d6ra02136k ↗Kurz gefasst
Kommentar in der Zeitschrift RSC Advances, 2026. Verfasst von Boris Cvek. Beteiligte Einrichtung: Palacky University Olomouc Czech Republic cvekb@seznam.cz. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Will the real hero please step forward? Diethylthiomethyl carbamate, a metabolite of disulfiram (Antabuse) blocks ALDH while disulfiram itself has no proven biological activity.
Autor:innen und Institutionen
- Palacky University Olomouc Czech Republic cvekb@seznam.cz.
ORCID-Profile: Boris Cvek
Zitieren
APA
Cvek, B. (2026). Comment on “Disulfiram as an anti-inflammatory agent: mechanisms, nano-delivery strategies, and applications in non-oncologic diseases” by Q. Jiang, M. Jiang, Y. Lv, X. Zhang, S. Wang and J. Zhao, RSC Adv. , 2025, 15 , 36344. RSC Advances, 16(34), 33511-33512. https://doi.org/10.1039/d6ra02136k
Vancouver
Cvek B. Comment on “Disulfiram as an anti-inflammatory agent: mechanisms, nano-delivery strategies, and applications in non-oncologic diseases” by Q. Jiang, M. Jiang, Y. Lv, X. Zhang, S. Wang and J. Zhao, RSC Adv. , 2025, 15 , 36344. RSC Advances. 2026;16(34):33511-33512. doi:10.1039/d6ra02136k
BibTeX
@article{Cvek2026,
author = {Cvek, Boris},
title = {Comment on “Disulfiram as an anti-inflammatory agent: mechanisms, nano-delivery strategies, and applications in non-oncologic diseases” by Q. Jiang, M. Jiang, Y. Lv, X. Zhang, S. Wang and J. Zhao, RSC Adv. , 2025, 15 , 36344},
journal = {RSC Advances},
year = {2026},
volume = {16},
number = {34},
pages = {33511--33512},
doi = {10.1039/d6ra02136k}
}
EUVIMED